Hafliger (1) synthesized a series of iminodibenzyl compounds which were found to possess antihistaminic, anticholinergic, sedative and analgesic properties. It was only after a clinical trial by Kuhn (2) that G 22355 (imipramine) "emerged as an antidepres sant". The exact mechanism of the antidepressant action of imipramine (IMI), its deriva tive desmethylimipramine (DMI) and its analogue amitriptyline (AMI) is not yet estab lished. These agents have been shown to antagonise reserpine induced muscular rigidity and this effect has been attributed to their central cholinolytic activity (3, 4). Another structurally related antidepressant, orphenadrine, has been reported to possess both central (5) and peripheral (6) muscle relaxant properties. We have, earlier, reported the inhibi tion of myoneural transmissson by IMI, DMI and AMI (7). Prolonged inhibition of linguomandibular reflex by low doses of these agents as compared to short lived action of mephenesin (8) prompted us to find out if these agents fulfill all the criteria essential for a central muscle relaxant. Accordingly, these drugs were subjected to various test procedures like effect on behaviour, effect on polysynaptic linguomandibular reflex, effect on facilitatory influence of reticular formation on patellar reflex and the effect on dece rebrate muscular rigidity in cat.
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METHODS
The present investigation was carried out in 12 rabbits (1.0-1.5 kg) and 38 adult cats (2.6-4.5 kg) irrespective of their sex. During experiments in anaesthetised animal, vagi were cut as a routine and animal maintained on artificial positive pressure respira tion. Blood pressure was recorded from a common carotid artery through a mercury manometer and a polythene tube was passed in a femoral vein.
Behavioral studies were carried out in rabbits. The drugs were injected intravenously and animals observed for three hours. Polysynaptic linguomandibular reflex (LMR) was elicited in cat, under pentobarbitone (35 m /kg i.p.) anaesthesia, by stimulating (2-4 V, 5-10 msec duration, 1 shock/sec) the root of the tongue according to the technique of King and Unna (9) . Movement of the lower jaw was recorded through a system of pulleys on smoked kymograph paper. Drugs were injected into a lateral cerebral ventricle according to the technique of Feldberg and Sherwood (10). Contractions of the gastrocnemius muscle due to electrical stimula tion of the sciatic nerve (0.2-0.4 V, 1 msec duration , 1 shock/sec) were used as control for peripheral neuromuscular transmission .
Monosynaptic patellar reflex and its facilitation due to electrical stimulation of the bul bar reticular formation was elicited in cat anaesthetised with ether and maintained on chloralose (60 mg/kg i.v.). The quadriceps tendon was tapped every 5 seconds by means of an electromagnetic hammer and movement of the limb was recorded through a system of pulleys on kymograph (11). Polysynaptic facilitation of the reflex was obtained by stereotaxically stimulating (2-6 V, 1-2 msec duration , 100 shocks/sec) the dorsolateral facilitatory area of reticular formation for 15 seconds using a concentric bipolar needle electrode. The electrode placement was aided by the parameters described by Henneman et al. (12) .
All stimuli were derived from a Grass model S4 electronic stimulator delivering rectangular pulses. Decerebrate rigidity in cat was induced by making a mid-collicular section under ether anaesthesia. Patellar reflex was recorded at the same time . Ether was stopped after decerebration and the drug was injected intravenously . (middle panels) and amitriptyline-1.25°a (lower panels) to the calamus scriptorius on the blood pressure (upper tracing in all the panels) and patellar reflex (PR). PR was elicited by tapping the quadriceps tendon by means of an electromagnetic hammer every 5 seconds and its facilita tion was obtained by electrical stimulation (marked by signal) of the brainstem reticular forma tion (rectangular pulses of 2.0 V, 1 msec duration and 100,/sec frequency). Note the peak effect at 15 minutes (middle panels) and partial recovery at 200 minutes.
ed anaffected (see Fig. 1 ). DMI and AMI, similarly, also caused inhibition of the LMR.
The activity ratio of these compounds, taking mephenesin as one (see C. Effect on pol ysynaptic facilitation o f monosynaptic patellar reflex (PR) Polysynaptic facilitation of the patellar reflex (PR) was obtained by stimulation of a facilitatory area of brainstem reticular formation (2-6 V, 100 shocks/sec of 1-2 msec duration for 15 seconds). Fig. 3 shows the typical effects of topical application of IMI (1.25%), DMI (2.0%) and AMI (1.25%) on the PR itself and its reticular facilitation. All the three drugs decreased the amplitude of the PR and abolished the polysynaptic facilitation of this reflex. These effects were gradual in onset and the maximum effect was observed after 15 minutes. Partial recovery was observed after 200 minutes.
D. Effect on decerebrate muscular rigidity in cat Muscular rigidity was obtained by manually sectioning the brainstem at the mid collicular level. At the height of this rigidity, intravenous administration of IMI (2.0 mg/kg), DMI (2.5 mg/kg) and AMI (2.0 mg/kg) counteracted the abnormal muscle tone. Fig. 4 demonstrates the gradual recovery from the decerebrate rigidity following intra venous injection of IMI (2.0 mg/kg). At 200 minutes muscle tone was even lower than the control level and amplitude of PR was also bigger. It is compared to a control experiment (upper panels) where no drug was given and the extent of the rigidity was observed for over three hours. In such an experiment after midcollicular section there was decrease in the amplitude of PR and marked increase in the muscle tone. Recovery of the muscle tone was not obtained even at 200 minutes although amplitude of PR practically returned to normal. DISCUSSION
In the present study imipramine, desmethylimipramine and amitriptyline were found to satisfy several criteria considered to be necessary for an agent to be labelled a central muscle relaxant. Intravenous administration of these agents in conscious rabbits caused sedation, drowsiness, decreased motor activity, relaxation of abdominal muscles and rever sible hind limb paralysis without head drop or loss of consciousness. Prolonged inhibi tion of linguomandibular reflex after intracerebroventricular injection of imipramine as compared to short lived action of mephenesin pointed to the distinct advantage of former over the latter agent as central muscle relaxant. The facilitation of the patellar reflex induced by stimulation of brainstem reticular formation was abolished by topical ap plication of these agents at the calamus scriptorius. The amplitude of the patellar reflex was also decreased at the same time. Thus imipramine, desmethylimipramine and ami triptyline seem to inhibit the facilitatory synapses of the brainstem reticular formation. But the effect on the polysynaptic facilitation did not seem to be specific since mono synaptic patellar reflex was also depressed at the same time. Decerebrate rigidity in cat was antagonised by all the three agents which is an important property of central muscle relaxants.
Our studies clearly demonstrate the potent central muscle relaxant activity of imipra mine, desmetylimipramine and amitriptyline. Increased muscle tone is a common ac companiment of reserpine syndrome and is consistently present in patients of depressive psychosis. These agents antagonise the increased motor activity induced by reserpine (3). Clinically they are effective antidepressants.
In view of the increased muscle tone in depressive states and the effective central muscle relaxant property of these agents, it seems probable that this property of these agents might be playing some role in their antidepressant action.
A controlled clinical trial of imipramine and its congeners as central muscle relaxants in certain spastic musclar disorders seems warranted.
SUMMARY
Intravenous administration of imipramine, desmethylimipramine and amitriptyline in conscious rabbits produced sedation, hind limb paralysis and relaxation of abdominal muscles, without head drop or loss of consciousness.
The polysynaptic linguomandibular reflex was depressed by intracerebroventricular administration of these agents. Facilita tion of the patellar reflex induced by stimulation of the brainstem reticular formation was also blocked. Furthermore, they abolished the muscular rigidity induced by decerebra tion in cat. Thus these agents seem to fulfill the criteria of a central muscle relaxant and may prove of value in certain spastic muscular disorders.
